Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Elsevier Pharma Blog Makes Feedspot’s Top 50

Posted on January 30th, 2017 by in Pharma R&D

The popular content reader Feedspot recently announced its ranking of the Top 50 Pharma Blogs, and Elsevier is pleased that its own pharma blog, Pharma R&D Today, made the list! Continue reading “Elsevier Pharma Blog Makes Feedspot’s Top 50” »

The Latest in Bioinformatics Solutions

Posted on December 5th, 2016 by in Pharma R&D

Next generation sequencing and other innovative developments in biological research are helping scientists understand disease and drug activity at a level never before thought possible. Continue reading “The Latest in Bioinformatics Solutions” »

Easing the Pain in Monitoring Literature for Adverse Drug Events

Posted on September 20th, 2016 by in Pharmacovigilance

Over the past year, we have heard about the various challenges associated with the cumbersome task of monitoring scientific literature for adverse drug events (AE) from thought leaders on this blog. Pharmacovigilance professionals have written about the literature monitoring and review process, the recent EMA Medical Literature Monitoring initiative, and the importance of literature search strategies. Continue reading “Easing the Pain in Monitoring Literature for Adverse Drug Events” »

Elsevier and Illumina: A meeting of mind and spirit

Posted on August 22nd, 2016 by in Pharma R&D

One of the strongest arguments for using the molecular biology modeling tool Pathway Studio is the rich content underlying its knowledge database. This was driven home recently in a conversation with the DNA/RNA sequencing company Illumina. Continue reading “Elsevier and Illumina: A meeting of mind and spirit” »

  1. 1
  2. 2